The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Zafirlukast Market Research Report 2024
Synopsis
Zarlukast is a white solid with a melting point (º C) of 139. Its solubility is slightly soluble in methanol, soluble in tetrahydrofuran, acetone and dimethyl sulfoxide, and almost insoluble in water. Clinically, zarlukast is a leukotriene receptor antagonist, and its indication is the prevention and long-term treatment of asthma.
The global Zafirlukast market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Zafirlukast is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Zafirlukast is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Zafirlukast in Leukotriene Antagonist is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Zafirlukast include Target Molecule Corp., Merck, Cayman Chemical Company, APExBIO Technology LLC, Carbosynth Ltd, Biorbyt, Toronto Research Chemicals, Glr Innovations and Medical Isotopes, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Zafirlukast, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zafirlukast.
Report Scope
The Zafirlukast market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zafirlukast market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zafirlukast companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Target Molecule Corp.
Merck
Cayman Chemical Company
APExBIO Technology LLC
Carbosynth Ltd
Biorbyt
Toronto Research Chemicals
Glr Innovations
Medical Isotopes, Inc.
AvaChem Scientific
Tokyo Chemical Industry Co.,Ltd.
Carbone scientific
Santa Cruz Biotechnology, Inc.
Chemos GmbH and Co. KG
3B Scientific
MedChemExpress LLC
AK Scientific, Inc.
CarboMer, Inc.
Creative Enzymes
Combi-Blocks
Chromo Laboratories India Pvt Ltd
Dr.Reddy's Laboratories Limited
Shanghai Beilang Biotechnology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Shanghai Acmec Biochemical Co.,Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Dalian Meilun Biotechnology Co., Ltd
BOC Sciences
Standardpharm Co., Ltd.
Aibixin (Shanghai) Biotechnology Co., Ltd
Glpbio
Abmole Bioscience Inc.
Segment by Type
10 mg
20 mg
Segment by Application
Leukotriene Antagonist
Treatment of Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Zafirlukast companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Zarlukast is a white solid with a melting point (º C) of 139. Its solubility is slightly soluble in methanol, soluble in tetrahydrofuran, acetone and dimethyl sulfoxide, and almost insoluble in water. Clinically, zarlukast is a leukotriene receptor antagonist, and its indication is the prevention and long-term treatment of asthma.
The global Zafirlukast market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Zafirlukast is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Zafirlukast is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Zafirlukast in Leukotriene Antagonist is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Zafirlukast include Target Molecule Corp., Merck, Cayman Chemical Company, APExBIO Technology LLC, Carbosynth Ltd, Biorbyt, Toronto Research Chemicals, Glr Innovations and Medical Isotopes, Inc., etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Zafirlukast, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Zafirlukast.
Report Scope
The Zafirlukast market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Zafirlukast market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Zafirlukast companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Target Molecule Corp.
Merck
Cayman Chemical Company
APExBIO Technology LLC
Carbosynth Ltd
Biorbyt
Toronto Research Chemicals
Glr Innovations
Medical Isotopes, Inc.
AvaChem Scientific
Tokyo Chemical Industry Co.,Ltd.
Carbone scientific
Santa Cruz Biotechnology, Inc.
Chemos GmbH and Co. KG
3B Scientific
MedChemExpress LLC
AK Scientific, Inc.
CarboMer, Inc.
Creative Enzymes
Combi-Blocks
Chromo Laboratories India Pvt Ltd
Dr.Reddy's Laboratories Limited
Shanghai Beilang Biotechnology Co., Ltd
Shanghai Yuanye Bio-Technology Co., Ltd
Shanghai Acmec Biochemical Co.,Ltd
Shanghai McLin Biochemical Technology Co., Ltd
Dalian Meilun Biotechnology Co., Ltd
BOC Sciences
Standardpharm Co., Ltd.
Aibixin (Shanghai) Biotechnology Co., Ltd
Glpbio
Abmole Bioscience Inc.
Segment by Type
10 mg
20 mg
Segment by Application
Leukotriene Antagonist
Treatment of Asthma
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Zafirlukast companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Zafirlukast Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 10 mg
1.2.3 20 mg
1.3 Market by Application
1.3.1 Global Zafirlukast Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Leukotriene Antagonist
1.3.3 Treatment of Asthma
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Zafirlukast Market Perspective (2019-2030)
2.2 Zafirlukast Growth Trends by Region
2.2.1 Global Zafirlukast Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Zafirlukast Historic Market Size by Region (2019-2024)
2.2.3 Zafirlukast Forecasted Market Size by Region (2025-2030)
2.3 Zafirlukast Market Dynamics
2.3.1 Zafirlukast Industry Trends
2.3.2 Zafirlukast Market Drivers
2.3.3 Zafirlukast Market Challenges
2.3.4 Zafirlukast Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Zafirlukast Players by Revenue
3.1.1 Global Top Zafirlukast Players by Revenue (2019-2024)
3.1.2 Global Zafirlukast Revenue Market Share by Players (2019-2024)
3.2 Global Zafirlukast Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Zafirlukast Revenue
3.4 Global Zafirlukast Market Concentration Ratio
3.4.1 Global Zafirlukast Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Zafirlukast Revenue in 2023
3.5 Zafirlukast Key Players Head office and Area Served
3.6 Key Players Zafirlukast Product Solution and Service
3.7 Date of Enter into Zafirlukast Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Zafirlukast Breakdown Data by Type
4.1 Global Zafirlukast Historic Market Size by Type (2019-2024)
4.2 Global Zafirlukast Forecasted Market Size by Type (2025-2030)
5 Zafirlukast Breakdown Data by Application
5.1 Global Zafirlukast Historic Market Size by Application (2019-2024)
5.2 Global Zafirlukast Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Zafirlukast Market Size (2019-2030)
6.2 North America Zafirlukast Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Zafirlukast Market Size by Country (2019-2024)
6.4 North America Zafirlukast Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Zafirlukast Market Size (2019-2030)
7.2 Europe Zafirlukast Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Zafirlukast Market Size by Country (2019-2024)
7.4 Europe Zafirlukast Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Zafirlukast Market Size (2019-2030)
8.2 Asia-Pacific Zafirlukast Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Zafirlukast Market Size by Region (2019-2024)
8.4 Asia-Pacific Zafirlukast Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Zafirlukast Market Size (2019-2030)
9.2 Latin America Zafirlukast Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Zafirlukast Market Size by Country (2019-2024)
9.4 Latin America Zafirlukast Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Zafirlukast Market Size (2019-2030)
10.2 Middle East & Africa Zafirlukast Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Zafirlukast Market Size by Country (2019-2024)
10.4 Middle East & Africa Zafirlukast Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Target Molecule Corp.
11.1.1 Target Molecule Corp. Company Detail
11.1.2 Target Molecule Corp. Business Overview
11.1.3 Target Molecule Corp. Zafirlukast Introduction
11.1.4 Target Molecule Corp. Revenue in Zafirlukast Business (2019-2024)
11.1.5 Target Molecule Corp. Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Zafirlukast Introduction
11.2.4 Merck Revenue in Zafirlukast Business (2019-2024)
11.2.5 Merck Recent Development
11.3 Cayman Chemical Company
11.3.1 Cayman Chemical Company Company Detail
11.3.2 Cayman Chemical Company Business Overview
11.3.3 Cayman Chemical Company Zafirlukast Introduction
11.3.4 Cayman Chemical Company Revenue in Zafirlukast Business (2019-2024)
11.3.5 Cayman Chemical Company Recent Development
11.4 APExBIO Technology LLC
11.4.1 APExBIO Technology LLC Company Detail
11.4.2 APExBIO Technology LLC Business Overview
11.4.3 APExBIO Technology LLC Zafirlukast Introduction
11.4.4 APExBIO Technology LLC Revenue in Zafirlukast Business (2019-2024)
11.4.5 APExBIO Technology LLC Recent Development
11.5 Carbosynth Ltd
11.5.1 Carbosynth Ltd Company Detail
11.5.2 Carbosynth Ltd Business Overview
11.5.3 Carbosynth Ltd Zafirlukast Introduction
11.5.4 Carbosynth Ltd Revenue in Zafirlukast Business (2019-2024)
11.5.5 Carbosynth Ltd Recent Development
11.6 Biorbyt
11.6.1 Biorbyt Company Detail
11.6.2 Biorbyt Business Overview
11.6.3 Biorbyt Zafirlukast Introduction
11.6.4 Biorbyt Revenue in Zafirlukast Business (2019-2024)
11.6.5 Biorbyt Recent Development
11.7 Toronto Research Chemicals
11.7.1 Toronto Research Chemicals Company Detail
11.7.2 Toronto Research Chemicals Business Overview
11.7.3 Toronto Research Chemicals Zafirlukast Introduction
11.7.4 Toronto Research Chemicals Revenue in Zafirlukast Business (2019-2024)
11.7.5 Toronto Research Chemicals Recent Development
11.8 Glr Innovations
11.8.1 Glr Innovations Company Detail
11.8.2 Glr Innovations Business Overview
11.8.3 Glr Innovations Zafirlukast Introduction
11.8.4 Glr Innovations Revenue in Zafirlukast Business (2019-2024)
11.8.5 Glr Innovations Recent Development
11.9 Medical Isotopes, Inc.
11.9.1 Medical Isotopes, Inc. Company Detail
11.9.2 Medical Isotopes, Inc. Business Overview
11.9.3 Medical Isotopes, Inc. Zafirlukast Introduction
11.9.4 Medical Isotopes, Inc. Revenue in Zafirlukast Business (2019-2024)
11.9.5 Medical Isotopes, Inc. Recent Development
11.10 AvaChem Scientific
11.10.1 AvaChem Scientific Company Detail
11.10.2 AvaChem Scientific Business Overview
11.10.3 AvaChem Scientific Zafirlukast Introduction
11.10.4 AvaChem Scientific Revenue in Zafirlukast Business (2019-2024)
11.10.5 AvaChem Scientific Recent Development
11.11 Tokyo Chemical Industry Co.,Ltd.
11.11.1 Tokyo Chemical Industry Co.,Ltd. Company Detail
11.11.2 Tokyo Chemical Industry Co.,Ltd. Business Overview
11.11.3 Tokyo Chemical Industry Co.,Ltd. Zafirlukast Introduction
11.11.4 Tokyo Chemical Industry Co.,Ltd. Revenue in Zafirlukast Business (2019-2024)
11.11.5 Tokyo Chemical Industry Co.,Ltd. Recent Development
11.12 Carbone scientific
11.12.1 Carbone scientific Company Detail
11.12.2 Carbone scientific Business Overview
11.12.3 Carbone scientific Zafirlukast Introduction
11.12.4 Carbone scientific Revenue in Zafirlukast Business (2019-2024)
11.12.5 Carbone scientific Recent Development
11.13 Santa Cruz Biotechnology, Inc.
11.13.1 Santa Cruz Biotechnology, Inc. Company Detail
11.13.2 Santa Cruz Biotechnology, Inc. Business Overview
11.13.3 Santa Cruz Biotechnology, Inc. Zafirlukast Introduction
11.13.4 Santa Cruz Biotechnology, Inc. Revenue in Zafirlukast Business (2019-2024)
11.13.5 Santa Cruz Biotechnology, Inc. Recent Development
11.14 Chemos GmbH and Co. KG
11.14.1 Chemos GmbH and Co. KG Company Detail
11.14.2 Chemos GmbH and Co. KG Business Overview
11.14.3 Chemos GmbH and Co. KG Zafirlukast Introduction
11.14.4 Chemos GmbH and Co. KG Revenue in Zafirlukast Business (2019-2024)
11.14.5 Chemos GmbH and Co. KG Recent Development
11.15 3B Scientific
11.15.1 3B Scientific Company Detail
11.15.2 3B Scientific Business Overview
11.15.3 3B Scientific Zafirlukast Introduction
11.15.4 3B Scientific Revenue in Zafirlukast Business (2019-2024)
11.15.5 3B Scientific Recent Development
11.16 MedChemExpress LLC
11.16.1 MedChemExpress LLC Company Detail
11.16.2 MedChemExpress LLC Business Overview
11.16.3 MedChemExpress LLC Zafirlukast Introduction
11.16.4 MedChemExpress LLC Revenue in Zafirlukast Business (2019-2024)
11.16.5 MedChemExpress LLC Recent Development
11.17 AK Scientific, Inc.
11.17.1 AK Scientific, Inc. Company Detail
11.17.2 AK Scientific, Inc. Business Overview
11.17.3 AK Scientific, Inc. Zafirlukast Introduction
11.17.4 AK Scientific, Inc. Revenue in Zafirlukast Business (2019-2024)
11.17.5 AK Scientific, Inc. Recent Development
11.18 CarboMer, Inc.
11.18.1 CarboMer, Inc. Company Detail
11.18.2 CarboMer, Inc. Business Overview
11.18.3 CarboMer, Inc. Zafirlukast Introduction
11.18.4 CarboMer, Inc. Revenue in Zafirlukast Business (2019-2024)
11.18.5 CarboMer, Inc. Recent Development
11.19 Creative Enzymes
11.19.1 Creative Enzymes Company Detail
11.19.2 Creative Enzymes Business Overview
11.19.3 Creative Enzymes Zafirlukast Introduction
11.19.4 Creative Enzymes Revenue in Zafirlukast Business (2019-2024)
11.19.5 Creative Enzymes Recent Development
11.20 Combi-Blocks
11.20.1 Combi-Blocks Company Detail
11.20.2 Combi-Blocks Business Overview
11.20.3 Combi-Blocks Zafirlukast Introduction
11.20.4 Combi-Blocks Revenue in Zafirlukast Business (2019-2024)
11.20.5 Combi-Blocks Recent Development
11.21 Chromo Laboratories India Pvt Ltd
11.21.1 Chromo Laboratories India Pvt Ltd Company Detail
11.21.2 Chromo Laboratories India Pvt Ltd Business Overview
11.21.3 Chromo Laboratories India Pvt Ltd Zafirlukast Introduction
11.21.4 Chromo Laboratories India Pvt Ltd Revenue in Zafirlukast Business (2019-2024)
11.21.5 Chromo Laboratories India Pvt Ltd Recent Development
11.22 Dr.Reddy's Laboratories Limited
11.22.1 Dr.Reddy's Laboratories Limited Company Detail
11.22.2 Dr.Reddy's Laboratories Limited Business Overview
11.22.3 Dr.Reddy's Laboratories Limited Zafirlukast Introduction
11.22.4 Dr.Reddy's Laboratories Limited Revenue in Zafirlukast Business (2019-2024)
11.22.5 Dr.Reddy's Laboratories Limited Recent Development
11.23 Shanghai Beilang Biotechnology Co., Ltd
11.23.1 Shanghai Beilang Biotechnology Co., Ltd Company Detail
11.23.2 Shanghai Beilang Biotechnology Co., Ltd Business Overview
11.23.3 Shanghai Beilang Biotechnology Co., Ltd Zafirlukast Introduction
11.23.4 Shanghai Beilang Biotechnology Co., Ltd Revenue in Zafirlukast Business (2019-2024)
11.23.5 Shanghai Beilang Biotechnology Co., Ltd Recent Development
11.24 Shanghai Yuanye Bio-Technology Co., Ltd
11.24.1 Shanghai Yuanye Bio-Technology Co., Ltd Company Detail
11.24.2 Shanghai Yuanye Bio-Technology Co., Ltd Business Overview
11.24.3 Shanghai Yuanye Bio-Technology Co., Ltd Zafirlukast Introduction
11.24.4 Shanghai Yuanye Bio-Technology Co., Ltd Revenue in Zafirlukast Business (2019-2024)
11.24.5 Shanghai Yuanye Bio-Technology Co., Ltd Recent Development
11.25 Shanghai Acmec Biochemical Co.,Ltd
11.25.1 Shanghai Acmec Biochemical Co.,Ltd Company Detail
11.25.2 Shanghai Acmec Biochemical Co.,Ltd Business Overview
11.25.3 Shanghai Acmec Biochemical Co.,Ltd Zafirlukast Introduction
11.25.4 Shanghai Acmec Biochemical Co.,Ltd Revenue in Zafirlukast Business (2019-2024)
11.25.5 Shanghai Acmec Biochemical Co.,Ltd Recent Development
11.26 Shanghai McLin Biochemical Technology Co., Ltd
11.26.1 Shanghai McLin Biochemical Technology Co., Ltd Company Detail
11.26.2 Shanghai McLin Biochemical Technology Co., Ltd Business Overview
11.26.3 Shanghai McLin Biochemical Technology Co., Ltd Zafirlukast Introduction
11.26.4 Shanghai McLin Biochemical Technology Co., Ltd Revenue in Zafirlukast Business (2019-2024)
11.26.5 Shanghai McLin Biochemical Technology Co., Ltd Recent Development
11.27 Dalian Meilun Biotechnology Co., Ltd
11.27.1 Dalian Meilun Biotechnology Co., Ltd Company Detail
11.27.2 Dalian Meilun Biotechnology Co., Ltd Business Overview
11.27.3 Dalian Meilun Biotechnology Co., Ltd Zafirlukast Introduction
11.27.4 Dalian Meilun Biotechnology Co., Ltd Revenue in Zafirlukast Business (2019-2024)
11.27.5 Dalian Meilun Biotechnology Co., Ltd Recent Development
11.28 BOC Sciences
11.28.1 BOC Sciences Company Detail
11.28.2 BOC Sciences Business Overview
11.28.3 BOC Sciences Zafirlukast Introduction
11.28.4 BOC Sciences Revenue in Zafirlukast Business (2019-2024)
11.28.5 BOC Sciences Recent Development
11.29 Standardpharm Co., Ltd.
11.29.1 Standardpharm Co., Ltd. Company Detail
11.29.2 Standardpharm Co., Ltd. Business Overview
11.29.3 Standardpharm Co., Ltd. Zafirlukast Introduction
11.29.4 Standardpharm Co., Ltd. Revenue in Zafirlukast Business (2019-2024)
11.29.5 Standardpharm Co., Ltd. Recent Development
11.30 Aibixin (Shanghai) Biotechnology Co., Ltd
11.30.1 Aibixin (Shanghai) Biotechnology Co., Ltd Company Detail
11.30.2 Aibixin (Shanghai) Biotechnology Co., Ltd Business Overview
11.30.3 Aibixin (Shanghai) Biotechnology Co., Ltd Zafirlukast Introduction
11.30.4 Aibixin (Shanghai) Biotechnology Co., Ltd Revenue in Zafirlukast Business (2019-2024)
11.30.5 Aibixin (Shanghai) Biotechnology Co., Ltd Recent Development
11.31 Glpbio
11.31.1 Glpbio Company Detail
11.31.2 Glpbio Business Overview
11.31.3 Glpbio Zafirlukast Introduction
11.31.4 Glpbio Revenue in Zafirlukast Business (2019-2024)
11.31.5 Glpbio Recent Development
11.32 Abmole Bioscience Inc.
11.32.1 Abmole Bioscience Inc. Company Detail
11.32.2 Abmole Bioscience Inc. Business Overview
11.32.3 Abmole Bioscience Inc. Zafirlukast Introduction
11.32.4 Abmole Bioscience Inc. Revenue in Zafirlukast Business (2019-2024)
11.32.5 Abmole Bioscience Inc. Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Zafirlukast Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of 10 mg
Table 3. Key Players of 20 mg
Table 4. Global Zafirlukast Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 5. Global Zafirlukast Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Zafirlukast Market Size by Region (2019-2024) & (US$ Million)
Table 7. Global Zafirlukast Market Share by Region (2019-2024)
Table 8. Global Zafirlukast Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 9. Global Zafirlukast Market Share by Region (2025-2030)
Table 10. Zafirlukast Market Trends
Table 11. Zafirlukast Market Drivers
Table 12. Zafirlukast Market Challenges
Table 13. Zafirlukast Market Restraints
Table 14. Global Zafirlukast Revenue by Players (2019-2024) & (US$ Million)
Table 15. Global Zafirlukast Market Share by Players (2019-2024)
Table 16. Global Top Zafirlukast Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zafirlukast as of 2023)
Table 17. Ranking of Global Top Zafirlukast Companies by Revenue (US$ Million) in 2023
Table 18. Global 5 Largest Players Market Share by Zafirlukast Revenue (CR5 and HHI) & (2019-2024)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Zafirlukast Product Solution and Service
Table 21. Date of Enter into Zafirlukast Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Zafirlukast Market Size by Type (2019-2024) & (US$ Million)
Table 24. Global Zafirlukast Revenue Market Share by Type (2019-2024)
Table 25. Global Zafirlukast Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 26. Global Zafirlukast Revenue Market Share by Type (2025-2030)
Table 27. Global Zafirlukast Market Size by Application (2019-2024) & (US$ Million)
Table 28. Global Zafirlukast Revenue Market Share by Application (2019-2024)
Table 29. Global Zafirlukast Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 30. Global Zafirlukast Revenue Market Share by Application (2025-2030)
Table 31. North America Zafirlukast Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 32. North America Zafirlukast Market Size by Country (2019-2024) & (US$ Million)
Table 33. North America Zafirlukast Market Size by Country (2025-2030) & (US$ Million)
Table 34. Europe Zafirlukast Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 35. Europe Zafirlukast Market Size by Country (2019-2024) & (US$ Million)
Table 36. Europe Zafirlukast Market Size by Country (2025-2030) & (US$ Million)
Table 37. Asia-Pacific Zafirlukast Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 38. Asia-Pacific Zafirlukast Market Size by Region (2019-2024) & (US$ Million)
Table 39. Asia-Pacific Zafirlukast Market Size by Region (2025-2030) & (US$ Million)
Table 40. Latin America Zafirlukast Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 41. Latin America Zafirlukast Market Size by Country (2019-2024) & (US$ Million)
Table 42. Latin America Zafirlukast Market Size by Country (2025-2030) & (US$ Million)
Table 43. Middle East & Africa Zafirlukast Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 44. Middle East & Africa Zafirlukast Market Size by Country (2019-2024) & (US$ Million)
Table 45. Middle East & Africa Zafirlukast Market Size by Country (2025-2030) & (US$ Million)
Table 46. Target Molecule Corp. Company Detail
Table 47. Target Molecule Corp. Business Overview
Table 48. Target Molecule Corp. Zafirlukast Product
Table 49. Target Molecule Corp. Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 50. Target Molecule Corp. Recent Development
Table 51. Merck Company Detail
Table 52. Merck Business Overview
Table 53. Merck Zafirlukast Product
Table 54. Merck Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 55. Merck Recent Development
Table 56. Cayman Chemical Company Company Detail
Table 57. Cayman Chemical Company Business Overview
Table 58. Cayman Chemical Company Zafirlukast Product
Table 59. Cayman Chemical Company Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 60. Cayman Chemical Company Recent Development
Table 61. APExBIO Technology LLC Company Detail
Table 62. APExBIO Technology LLC Business Overview
Table 63. APExBIO Technology LLC Zafirlukast Product
Table 64. APExBIO Technology LLC Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 65. APExBIO Technology LLC Recent Development
Table 66. Carbosynth Ltd Company Detail
Table 67. Carbosynth Ltd Business Overview
Table 68. Carbosynth Ltd Zafirlukast Product
Table 69. Carbosynth Ltd Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 70. Carbosynth Ltd Recent Development
Table 71. Biorbyt Company Detail
Table 72. Biorbyt Business Overview
Table 73. Biorbyt Zafirlukast Product
Table 74. Biorbyt Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 75. Biorbyt Recent Development
Table 76. Toronto Research Chemicals Company Detail
Table 77. Toronto Research Chemicals Business Overview
Table 78. Toronto Research Chemicals Zafirlukast Product
Table 79. Toronto Research Chemicals Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 80. Toronto Research Chemicals Recent Development
Table 81. Glr Innovations Company Detail
Table 82. Glr Innovations Business Overview
Table 83. Glr Innovations Zafirlukast Product
Table 84. Glr Innovations Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 85. Glr Innovations Recent Development
Table 86. Medical Isotopes, Inc. Company Detail
Table 87. Medical Isotopes, Inc. Business Overview
Table 88. Medical Isotopes, Inc. Zafirlukast Product
Table 89. Medical Isotopes, Inc. Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 90. Medical Isotopes, Inc. Recent Development
Table 91. AvaChem Scientific Company Detail
Table 92. AvaChem Scientific Business Overview
Table 93. AvaChem Scientific Zafirlukast Product
Table 94. AvaChem Scientific Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 95. AvaChem Scientific Recent Development
Table 96. Tokyo Chemical Industry Co.,Ltd. Company Detail
Table 97. Tokyo Chemical Industry Co.,Ltd. Business Overview
Table 98. Tokyo Chemical Industry Co.,Ltd. Zafirlukast Product
Table 99. Tokyo Chemical Industry Co.,Ltd. Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 100. Tokyo Chemical Industry Co.,Ltd. Recent Development
Table 101. Carbone scientific Company Detail
Table 102. Carbone scientific Business Overview
Table 103. Carbone scientific Zafirlukast Product
Table 104. Carbone scientific Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 105. Carbone scientific Recent Development
Table 106. Santa Cruz Biotechnology, Inc. Company Detail
Table 107. Santa Cruz Biotechnology, Inc. Business Overview
Table 108. Santa Cruz Biotechnology, Inc. Zafirlukast Product
Table 109. Santa Cruz Biotechnology, Inc. Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 110. Santa Cruz Biotechnology, Inc. Recent Development
Table 111. Chemos GmbH and Co. KG Company Detail
Table 112. Chemos GmbH and Co. KG Business Overview
Table 113. Chemos GmbH and Co. KG Zafirlukast Product
Table 114. Chemos GmbH and Co. KG Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 115. Chemos GmbH and Co. KG Recent Development
Table 116. 3B Scientific Company Detail
Table 117. 3B Scientific Business Overview
Table 118. 3B Scientific Zafirlukast Product
Table 119. 3B Scientific Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 120. 3B Scientific Recent Development
Table 121. MedChemExpress LLC Company Detail
Table 122. MedChemExpress LLC Business Overview
Table 123. MedChemExpress LLC Zafirlukast Product
Table 124. MedChemExpress LLC Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 125. MedChemExpress LLC Recent Development
Table 126. AK Scientific, Inc. Company Detail
Table 127. AK Scientific, Inc. Business Overview
Table 128. AK Scientific, Inc. Zafirlukast Product
Table 129. AK Scientific, Inc. Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 130. AK Scientific, Inc. Recent Development
Table 131. CarboMer, Inc. Company Detail
Table 132. CarboMer, Inc. Business Overview
Table 133. CarboMer, Inc. Zafirlukast Product
Table 134. CarboMer, Inc. Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 135. CarboMer, Inc. Recent Development
Table 136. Creative Enzymes Company Detail
Table 137. Creative Enzymes Business Overview
Table 138. Creative Enzymes Zafirlukast Product
Table 139. Creative Enzymes Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 140. Creative Enzymes Recent Development
Table 141. Combi-Blocks Company Detail
Table 142. Combi-Blocks Business Overview
Table 143. Combi-Blocks Zafirlukast Product
Table 144. Combi-Blocks Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 145. Combi-Blocks Recent Development
Table 146. Chromo Laboratories India Pvt Ltd Company Detail
Table 147. Chromo Laboratories India Pvt Ltd Business Overview
Table 148. Chromo Laboratories India Pvt Ltd Zafirlukast Product
Table 149. Chromo Laboratories India Pvt Ltd Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 150. Chromo Laboratories India Pvt Ltd Recent Development
Table 151. Dr.Reddy's Laboratories Limited Company Detail
Table 152. Dr.Reddy's Laboratories Limited Business Overview
Table 153. Dr.Reddy's Laboratories Limited Zafirlukast Product
Table 154. Dr.Reddy's Laboratories Limited Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 155. Dr.Reddy's Laboratories Limited Recent Development
Table 156. Shanghai Beilang Biotechnology Co., Ltd Company Detail
Table 157. Shanghai Beilang Biotechnology Co., Ltd Business Overview
Table 158. Shanghai Beilang Biotechnology Co., Ltd Zafirlukast Product
Table 159. Shanghai Beilang Biotechnology Co., Ltd Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 160. Shanghai Beilang Biotechnology Co., Ltd Recent Development
Table 161. Shanghai Yuanye Bio-Technology Co., Ltd Company Detail
Table 162. Shanghai Yuanye Bio-Technology Co., Ltd Business Overview
Table 163. Shanghai Yuanye Bio-Technology Co., Ltd Zafirlukast Product
Table 164. Shanghai Yuanye Bio-Technology Co., Ltd Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 165. Shanghai Yuanye Bio-Technology Co., Ltd Recent Development
Table 166. Shanghai Acmec Biochemical Co.,Ltd Company Detail
Table 167. Shanghai Acmec Biochemical Co.,Ltd Business Overview
Table 168. Shanghai Acmec Biochemical Co.,Ltd Zafirlukast Product
Table 169. Shanghai Acmec Biochemical Co.,Ltd Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 170. Shanghai Acmec Biochemical Co.,Ltd Recent Development
Table 171. Shanghai McLin Biochemical Technology Co., Ltd Company Detail
Table 172. Shanghai McLin Biochemical Technology Co., Ltd Business Overview
Table 173. Shanghai McLin Biochemical Technology Co., Ltd Zafirlukast Product
Table 174. Shanghai McLin Biochemical Technology Co., Ltd Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 175. Shanghai McLin Biochemical Technology Co., Ltd Recent Development
Table 176. Dalian Meilun Biotechnology Co., Ltd Company Detail
Table 177. Dalian Meilun Biotechnology Co., Ltd Business Overview
Table 178. Dalian Meilun Biotechnology Co., Ltd Zafirlukast Product
Table 179. Dalian Meilun Biotechnology Co., Ltd Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 180. Dalian Meilun Biotechnology Co., Ltd Recent Development
Table 181. BOC Sciences Company Detail
Table 182. BOC Sciences Business Overview
Table 183. BOC Sciences Zafirlukast Product
Table 184. BOC Sciences Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 185. BOC Sciences Recent Development
Table 186. Standardpharm Co., Ltd. Company Detail
Table 187. Standardpharm Co., Ltd. Business Overview
Table 188. Standardpharm Co., Ltd. Zafirlukast Product
Table 189. Standardpharm Co., Ltd. Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 190. Standardpharm Co., Ltd. Recent Development
Table 191. Aibixin (Shanghai) Biotechnology Co., Ltd Company Detail
Table 192. Aibixin (Shanghai) Biotechnology Co., Ltd Business Overview
Table 193. Aibixin (Shanghai) Biotechnology Co., Ltd Zafirlukast Product
Table 194. Aibixin (Shanghai) Biotechnology Co., Ltd Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 195. Aibixin (Shanghai) Biotechnology Co., Ltd Recent Development
Table 196. Glpbio Company Detail
Table 197. Glpbio Business Overview
Table 198. Glpbio Zafirlukast Product
Table 199. Glpbio Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 200. Glpbio Recent Development
Table 201. Abmole Bioscience Inc. Company Detail
Table 202. Abmole Bioscience Inc. Business Overview
Table 203. Abmole Bioscience Inc. Zafirlukast Product
Table 204. Abmole Bioscience Inc. Revenue in Zafirlukast Business (2019-2024) & (US$ Million)
Table 205. Abmole Bioscience Inc. Recent Development
Table 206. Research Programs/Design for This Report
Table 207. Key Data Information from Secondary Sources
Table 208. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Zafirlukast Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Zafirlukast Market Share by Type: 2023 VS 2030
Figure 3. 10 mg Features
Figure 4. 20 mg Features
Figure 5. Global Zafirlukast Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 6. Global Zafirlukast Market Share by Application: 2023 VS 2030
Figure 7. Leukotriene Antagonist Case Studies
Figure 8. Treatment of Asthma Case Studies
Figure 9. Zafirlukast Report Years Considered
Figure 10. Global Zafirlukast Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 11. Global Zafirlukast Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 12. Global Zafirlukast Market Share by Region: 2023 VS 2030
Figure 13. Global Zafirlukast Market Share by Players in 2023
Figure 14. Global Top Zafirlukast Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Zafirlukast as of 2023)
Figure 15. The Top 10 and 5 Players Market Share by Zafirlukast Revenue in 2023
Figure 16. North America Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 17. North America Zafirlukast Market Share by Country (2019-2030)
Figure 18. United States Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 19. Canada Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Europe Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Zafirlukast Market Share by Country (2019-2030)
Figure 22. Germany Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 23. France Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. U.K. Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. Italy Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Russia Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Nordic Countries Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Asia-Pacific Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Zafirlukast Market Share by Region (2019-2030)
Figure 30. China Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 31. Japan Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. South Korea Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. Southeast Asia Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. India Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. Australia Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Latin America Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Zafirlukast Market Share by Country (2019-2030)
Figure 38. Mexico Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 39. Brazil Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Zafirlukast Market Share by Country (2019-2030)
Figure 42. Turkey Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 43. Saudi Arabia Zafirlukast Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Target Molecule Corp. Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 45. Merck Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 46. Cayman Chemical Company Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 47. APExBIO Technology LLC Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 48. Carbosynth Ltd Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 49. Biorbyt Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 50. Toronto Research Chemicals Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 51. Glr Innovations Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 52. Medical Isotopes, Inc. Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 53. AvaChem Scientific Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 54. Tokyo Chemical Industry Co.,Ltd. Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 55. Carbone scientific Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 56. Santa Cruz Biotechnology, Inc. Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 57. Chemos GmbH and Co. KG Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 58. 3B Scientific Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 59. MedChemExpress LLC Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 60. AK Scientific, Inc. Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 61. CarboMer, Inc. Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 62. Creative Enzymes Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 63. Combi-Blocks Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 64. Chromo Laboratories India Pvt Ltd Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 65. Dr.Reddy's Laboratories Limited Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 66. Shanghai Beilang Biotechnology Co., Ltd Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 67. Shanghai Yuanye Bio-Technology Co., Ltd Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 68. Shanghai Acmec Biochemical Co.,Ltd Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 69. Shanghai McLin Biochemical Technology Co., Ltd Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 70. Dalian Meilun Biotechnology Co., Ltd Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 71. BOC Sciences Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 72. Standardpharm Co., Ltd. Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 73. Aibixin (Shanghai) Biotechnology Co., Ltd Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 74. Glpbio Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 75. Abmole Bioscience Inc. Revenue Growth Rate in Zafirlukast Business (2019-2024)
Figure 76. Bottom-up and Top-down Approaches for This Report
Figure 77. Data Triangulation
Figure 78. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
